"Sequence analysis is a cornerstone of modern molecular genetics, yet it is difficult to provide researchers with an experience that is meaningful and cost effective"
Ocimum Biosolutions has licensed Genchek, comprehensive sequence analysis tool, to University of Washington, University of Virginia, Alcorn State University and Acuity Pharmaceuticals. Ocimum's CEO Anuradha Acharya remarked, "Genchek is our first and most mature product with almost four years of development work.
"The new version of Genchek is very comprehensive and can replace multiple tools used by researchers. "We are proud to add these prestigious organisations to our list of clients.
"Sequence analysis is a cornerstone of modern molecular genetics, yet it is difficult to provide researchers with an experience that is meaningful and cost effective.
"Genchek, a comprehensive, multi-platform, cost-effective, sequence analysis software package, is capable of handling and analysing high throughput biological data.
"We expect that Genchek will enhance their research work". Financial details of the deals were not disclosed.
